522: Generating Genomic Therapies to Treat Huntington's Disease and Other Conditions - Dr. Edward Rebar

30:58
 
Share
 

Manage episode 243911208 series 45619
By Dr. Marie McNeely, featuring top scientists speaking about their life and career in science 3 days a, Dr. Marie McNeely, and Featuring top scientists speaking about their life. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Dr. Edward Rebar is Senior Vice President and Chief Technology Officer at Sangamo Therapeutics. Ed and the team at Sangamo are developing genomic medicines. They use different techniques including gene therapy, ex vivo genome editing (using cells sourced from outside the body), in vivo genome editing (using a patient’s own cells within their body), and in vivo targeted gene regulation to downregulate their genes of interest. When Ed isn’t at work, he loves being outside with his wife, going to local parks, and visiting National Parks. When walking around observing nature, he tries to understand the story behind what he sees. He particularly enjoys exploring and pondering the amazing rock formations in Southern Utah. Ed earned his B.S. degree in biochemistry from Rutgers University and his Ph.D. in biophysics and structural biology from MIT. He conducted postdoctoral research at the University of California, Berkeley before joining the team at Sangamo in 1998. In our interview, Ed shares more about his life and research.

512 episodes